InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

Picard Medical, Inc.

PMI Clue Score35
United States Fiscal year ends December CIK 0002030617
$15.33 +35.19% Close, 13 Oct 2026
Alert on the numbers Alert on insider trades
Price $15.33 +57.23% Close, 13 Oct 2026

Closing prices at the end of each trading day, from 29 Aug 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2024Revenue4.4Operating income−13.7Net income−21.1Fiscal year 2025Revenue4.9 +12.5%Operating income−13.3Net income−27.0
FY2024FY2025
Revenue 4.4 4.9
Growth +12.5%
Operating income −13.7 −13.3
Net income −21.1 −27.0
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2024Gross margin−2.6%Operating margin−312.3%Net margin−479.5%Fiscal year 2025Gross margin−4.1%Operating margin−268.4%Net margin−546.6%
FY2024FY2025
Gross margin −2.6% −4.1%
Operating margin −312.3% −268.4%
Net margin −479.5% −546.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2024Operating cash flow−11.9Fiscal year 2025Operating cash flow−15.7
FY2024FY2025
Operating cash flow −11.9 −15.7

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash and securities
Fiscal year 2024Cash and securities0.1Shareholders’ equity−44.0Fiscal year 2025Cash and securities7.5Shareholders’ equity3.8
FY2024FY2025
Cash and securities 0.1 7.5
Shareholders’ equity −44.0 3.8

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
4.4 4.9
Growth +12.5%
4.5 5.1
−0.1 −0.2
Growth
3.4 3.0
10.2 10.0
−13.7 −13.3
Growth
−21.1 −27.0
−0.0 0.0
−21.1 −27.0
Growth
Per share
−2.99 −0.75
7.9 36.2

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 2 of 2 years on file.